NASDAQ: ATEC | Healthcare / Medical Devices & Instruments / USA |
12.58 | +0.7100 | +5.98% | Vol 1.54M | 1Y Perf 10.52% |
Dec 1st, 2023 16:00 DELAYED |
BID | 12.32 | ASK | 13.00 | ||
Open | 11.80 | Previous Close | 11.87 | ||
Pre-Market | - | After-Market | 12.58 | ||
- - | - -% |
Target Price | 15.72 | Analyst Rating | Strong Buy 1.15 | |
Potential % | 24.96 | Finscreener Ranking | + 38.95 | |
Insiders Trans % 3/6/12 mo. | -43/-71/-33 | Value Ranking | ☆ 33.24 | |
Insiders Value % 3/6/12 mo. | -89/-92/-62 | Growth Ranking | + 31.58 | |
Insiders Shares Cnt. % 3/6/12 mo. | -88/-90/-66 | Income Ranking | — - | |
Price Range Ratio 52W % | 37.40 | Earnings Rating | Sell | |
Market Cap | 1.71B | Earnings Date | 6th Nov 2023 | |
Alpha | 0.03 | Standard Deviation | 0.20 | |
Beta | 1.36 |
Today's Price Range 11.6912.63 | 52W Range 8.6619.14 | 5 Year PE Ratio Range -8.70-1.70 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Buy |
Performance | |||
---|---|---|---|
1 Week | 0.00% | ||
1 Month | 25.21% | ||
3 Months | -26.95% | ||
6 Months | -22.52% | ||
1 Year | 10.52% | ||
3 Years | 16.03% | ||
5 Years | 338.01% | ||
10 Years | 496.48% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -152.86 | |||
ROE last 12 Months | -436.45 | |||
ROA (5Y Avg) | -11.76 | |||
ROA last 12 Months | -30.76 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -36.72 | |||
Return on invested Capital Q | -9.49 | |||
Return on invested Capital Y | -8.66 | |||
Assets Turnover | 0.50 | |||
Receivables Turnover | 5.60 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-8.10 | ||||
91.76 | ||||
5.12 | ||||
6.40 | ||||
-12.00 | ||||
-0.80 | ||||
-9.45 | ||||
-0.21 | ||||
1.61B | ||||
Forward PE | -11.87 | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.20 | ||||
2.10 | ||||
0.97 | ||||
34.08 | ||||
-26.60 | ||||
Leverage Ratio | 60.50 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
65.70 | ||||
-47.40 | ||||
-34.50 | ||||
-39.30 | ||||
-47.84 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
244.92M | ||||
2.33 | ||||
35.24 | ||||
16.64 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2023 | -0.30 | -0.35 | -16.67 |
Q02 2023 | -0.30 | -0.43 | -43.33 |
Q01 2023 | -0.32 | -0.40 | -25.00 |
Q04 2022 | -0.30 | -0.33 | -10.00 |
Q03 2022 | -0.32 | -0.35 | -9.38 |
Q02 2022 | -0.35 | -0.36 | -2.86 |
Q01 2022 | -0.29 | -0.43 | -48.28 |
Q04 2021 | -0.31 | -0.40 | -29.03 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2023 QR | -0.27 | -3.85 | Negative |
12/2023 FY | -1.44 | -3.60 | Negative |
3/2024 QR | -0.25 | -4.17 | Negative |
12/2024 FY | -1.00 | -7.53 | Negative |
Next Report Date | - |
Estimated EPS Next Report | -0.30 |
Estimates Count | 5 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 1.54M |
Shares Outstanding | 136.30K |
Shares Float | 96.61M |
Trades Count | 16.63K |
Dollar Volume | 19.13M |
Avg. Volume | 1.63M |
Avg. Weekly Volume | 1.15M |
Avg. Monthly Volume | 1.95M |
Avg. Quarterly Volume | 1.80M |
Alphatec Holdings Inc. (NASDAQ: ATEC) stock closed at 11.87 per share at the end of the most recent trading day (a -0.59% change compared to the prior day closing price) with a volume of 1.51M shares and market capitalization of 1.71B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 227 people. Alphatec Holdings Inc. CEO is Patrick S Miles.
The one-year performance of Alphatec Holdings Inc. stock is 10.52%, while year-to-date (YTD) performance is -3.89%. ATEC stock has a five-year performance of 338.01%. Its 52-week range is between 8.66 and 19.14, which gives ATEC stock a 52-week price range ratio of 37.40%
Alphatec Holdings Inc. currently has a PE ratio of -8.10, a price-to-book (PB) ratio of 91.76, a price-to-sale (PS) ratio of 5.12, a price to cashflow ratio of 6.40, a PEG ratio of -, a ROA of -30.76%, a ROC of -36.72% and a ROE of -436.45%. The company’s profit margin is -47.84%, its EBITDA margin is -34.50%, and its revenue ttm is $244.92 Million , which makes it $2.33 revenue per share.
Of the last four earnings reports from Alphatec Holdings Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.30 for the next earnings report. Alphatec Holdings Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Alphatec Holdings Inc. is Strong Buy (1.15), with a target price of $15.72, which is +24.96% compared to the current price. The earnings rating for Alphatec Holdings Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Alphatec Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Alphatec Holdings Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 13.65, ATR14 : 0.59, CCI20 : 96.44, Chaikin Money Flow : 0.06, MACD : 0.19, Money Flow Index : 64.60, ROC : 16.37, RSI : 56.82, STOCH (14,3) : 84.62, STOCH RSI : 0.59, UO : 55.95, Williams %R : -15.38), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Alphatec Holdings Inc. in the last 12-months were: Altman Elizabeth (Sold 9 273 shares of value $149 666 ), Bakst Evan (Sold 8 700 shares of value $129 804 ), Berkowitz Mortimer (Option Excercise at a value of $755 559), Craig E. Hunsaker (Option Excercise at a value of $472 224), Craig E. Hunsaker (Sold 260 060 shares of value $3 836 124 ), David Mowry (Sold 9 500 shares of value $137 370 ), David P. Sponsel (Sold 36 823 shares of value $484 840 ), David R. Pelizzon (Buy at a value of $47 244), Healthcare Partners, LLC. L-5 (Option Excercise at a value of $8 211 112), Healthcare Partners, LLC. L-5 (Sold 1 700 000 shares of value $25 296 000 ), Hunsaker Craig (Option Excercise at a value of $472 224), Hunsaker Craig (Sold 518 150 shares of value $8 018 273 ), Hunsaker Craig E (Sold 107 029 shares of value $1 926 522 ), James L.L. Tullis (Sold 80 000 shares of value $1 013 100 ), Lish Scott (Option Excercise at a value of $47 226), Lish Scott (Sold 47 442 shares of value $688 287 ), Miles Patrick (Option Excercise at a value of $944 447), Miles Patrick (Sold 1 039 728 shares of value $974 244 306 ), Mortimer Berkowitz (Option Excercise at a value of $377 780), Patrick S Miles (Sold 680 353 shares of value $969 559 231 ), Paul Segal (Sold 0 shares of value $-7 000 000 ), Paul Segal (Sold 238 825 shares of value $3 572 974 ), Pelizzon David (Buy at a value of $47 244), Scott Lish (Option Excercise at a value of $47 226), Scott Lish (Sold 47 442 shares of value $688 287 ), Segal Paul (Sold 71 329 shares of value $1 080 634 ), Sponsel David (Sold 82 400 shares of value $1 284 720 ), Tullis James (Option Excercise at a value of $1 828 243), Tullis James (Sold 135 000 shares of value $2 031 300 ), Ward W. Woods (Option Excercise at a value of $1 888 890), Woods Ward (Option Excercise at a value of $1 888 890)
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Alphatec Holdings Inc is a medical technology company focused on the design, development, and advancement of products for the surgical treatment of spinal disorders. The firm's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
CEO: Patrick S Miles
Telephone: +1 760 431-9286
Address: 5818 El Camino Real, Carlsbad 92008, CA, US
Number of employees: 227
Tue, 31 Oct 2023 19:37 GMT Alphatec Holdings (ATEC) Gets a Buy from TD Cowen
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.